| Dakota Vision Center East | |
|
5012 S Bur Oak Pl, Sioux Falls, SD 57108-2228 | |
| (605) 361-1680 | |
| (605) 361-1590 |
| Full Name | Dakota Vision Center East |
|---|---|
| Type | Facility |
| Speciality | Optometrist |
| Location | 5012 S Bur Oak Pl, Sioux Falls, South Dakota |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134188600 | NPI | - | NPPES |
| 9202133 | Medicaid | SD | |
| 9202072 | Medicaid | SD | |
| 9202392 | Medicaid | SD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | T-155 (South Dakota) | Primary |
| 152W00000X | Optometrist | T-473 (South Dakota) | Secondary |
| 152W00000X | Optometrist | T-462 (South Dakota) | Secondary |
| Provider Name | Robert Victor Haeder |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1922068873 PECOS PAC ID: 6204855026 Enrollment ID: I20051123000086 |
News Archive
A recent Reuters article reported that America's pharmaceutical research and biotechnology companies don't expect an industry increase as a result of broader insurance coverage proposed in health care reform.
Can scientists rid malaria from the Third World by simply feeding algae genetically engineered with a vaccine? That's the question biologists at UC San Diego sought to answer after they demonstrated last May that algae can be engineered to produce a vaccine that blocks malaria transmission.
OncoSec Medical Inc., which is developing its advanced-stage OncoSec Medical System (OMS) ElectroOncology therapies to treat solid tumors, today announced positive interim analysis of data from 81 subjects in a Phase IV study of primary and locally recurrent squamous cell carcinoma of the head and neck (HNSCC) treated with OMS ElectroChemotherapy in Europe.
Scientists investigating the cancer-fighting properties of artesunate - a drug commonly used to treat malaria - have found early evidence that combining it with an existing cancer drug has the potential to make each drug more effective than when used alone. They also found that regular treatment breaks could improve success levels.
DePuy Synthes Spine announced it is expanding its collaboration with Brainlab through the worldwide launch of navigation-ready instrumentation for its leading spine systems, and an exclusive global agreement to co-market Airo Mobile Intraoperative CT by Brainlab.
› Verified 7 days ago
| Provider Name | Vance E Ankrum |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1881653442 PECOS PAC ID: 5395764112 Enrollment ID: I20051123000106 |
News Archive
A recent Reuters article reported that America's pharmaceutical research and biotechnology companies don't expect an industry increase as a result of broader insurance coverage proposed in health care reform.
Can scientists rid malaria from the Third World by simply feeding algae genetically engineered with a vaccine? That's the question biologists at UC San Diego sought to answer after they demonstrated last May that algae can be engineered to produce a vaccine that blocks malaria transmission.
OncoSec Medical Inc., which is developing its advanced-stage OncoSec Medical System (OMS) ElectroOncology therapies to treat solid tumors, today announced positive interim analysis of data from 81 subjects in a Phase IV study of primary and locally recurrent squamous cell carcinoma of the head and neck (HNSCC) treated with OMS ElectroChemotherapy in Europe.
Scientists investigating the cancer-fighting properties of artesunate - a drug commonly used to treat malaria - have found early evidence that combining it with an existing cancer drug has the potential to make each drug more effective than when used alone. They also found that regular treatment breaks could improve success levels.
DePuy Synthes Spine announced it is expanding its collaboration with Brainlab through the worldwide launch of navigation-ready instrumentation for its leading spine systems, and an exclusive global agreement to co-market Airo Mobile Intraoperative CT by Brainlab.
› Verified 7 days ago
| Provider Name | Paul G Sampson |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1336109289 PECOS PAC ID: 3577582394 Enrollment ID: I20051123000188 |
News Archive
A recent Reuters article reported that America's pharmaceutical research and biotechnology companies don't expect an industry increase as a result of broader insurance coverage proposed in health care reform.
Can scientists rid malaria from the Third World by simply feeding algae genetically engineered with a vaccine? That's the question biologists at UC San Diego sought to answer after they demonstrated last May that algae can be engineered to produce a vaccine that blocks malaria transmission.
OncoSec Medical Inc., which is developing its advanced-stage OncoSec Medical System (OMS) ElectroOncology therapies to treat solid tumors, today announced positive interim analysis of data from 81 subjects in a Phase IV study of primary and locally recurrent squamous cell carcinoma of the head and neck (HNSCC) treated with OMS ElectroChemotherapy in Europe.
Scientists investigating the cancer-fighting properties of artesunate - a drug commonly used to treat malaria - have found early evidence that combining it with an existing cancer drug has the potential to make each drug more effective than when used alone. They also found that regular treatment breaks could improve success levels.
DePuy Synthes Spine announced it is expanding its collaboration with Brainlab through the worldwide launch of navigation-ready instrumentation for its leading spine systems, and an exclusive global agreement to co-market Airo Mobile Intraoperative CT by Brainlab.
› Verified 7 days ago
| Provider Name | Jeffrey A Oakland |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1689754905 PECOS PAC ID: 1355340803 Enrollment ID: I20110512000093 |
News Archive
A recent Reuters article reported that America's pharmaceutical research and biotechnology companies don't expect an industry increase as a result of broader insurance coverage proposed in health care reform.
Can scientists rid malaria from the Third World by simply feeding algae genetically engineered with a vaccine? That's the question biologists at UC San Diego sought to answer after they demonstrated last May that algae can be engineered to produce a vaccine that blocks malaria transmission.
OncoSec Medical Inc., which is developing its advanced-stage OncoSec Medical System (OMS) ElectroOncology therapies to treat solid tumors, today announced positive interim analysis of data from 81 subjects in a Phase IV study of primary and locally recurrent squamous cell carcinoma of the head and neck (HNSCC) treated with OMS ElectroChemotherapy in Europe.
Scientists investigating the cancer-fighting properties of artesunate - a drug commonly used to treat malaria - have found early evidence that combining it with an existing cancer drug has the potential to make each drug more effective than when used alone. They also found that regular treatment breaks could improve success levels.
DePuy Synthes Spine announced it is expanding its collaboration with Brainlab through the worldwide launch of navigation-ready instrumentation for its leading spine systems, and an exclusive global agreement to co-market Airo Mobile Intraoperative CT by Brainlab.
› Verified 7 days ago
| Provider Name | Meghan E Montreal Steinocker |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1700174273 PECOS PAC ID: 0648442699 Enrollment ID: I20111017000449 |
News Archive
A recent Reuters article reported that America's pharmaceutical research and biotechnology companies don't expect an industry increase as a result of broader insurance coverage proposed in health care reform.
Can scientists rid malaria from the Third World by simply feeding algae genetically engineered with a vaccine? That's the question biologists at UC San Diego sought to answer after they demonstrated last May that algae can be engineered to produce a vaccine that blocks malaria transmission.
OncoSec Medical Inc., which is developing its advanced-stage OncoSec Medical System (OMS) ElectroOncology therapies to treat solid tumors, today announced positive interim analysis of data from 81 subjects in a Phase IV study of primary and locally recurrent squamous cell carcinoma of the head and neck (HNSCC) treated with OMS ElectroChemotherapy in Europe.
Scientists investigating the cancer-fighting properties of artesunate - a drug commonly used to treat malaria - have found early evidence that combining it with an existing cancer drug has the potential to make each drug more effective than when used alone. They also found that regular treatment breaks could improve success levels.
DePuy Synthes Spine announced it is expanding its collaboration with Brainlab through the worldwide launch of navigation-ready instrumentation for its leading spine systems, and an exclusive global agreement to co-market Airo Mobile Intraoperative CT by Brainlab.
› Verified 7 days ago
| Provider Name | Joel D Quist |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1134415789 PECOS PAC ID: 3870764038 Enrollment ID: I20160513001478 |
News Archive
A recent Reuters article reported that America's pharmaceutical research and biotechnology companies don't expect an industry increase as a result of broader insurance coverage proposed in health care reform.
Can scientists rid malaria from the Third World by simply feeding algae genetically engineered with a vaccine? That's the question biologists at UC San Diego sought to answer after they demonstrated last May that algae can be engineered to produce a vaccine that blocks malaria transmission.
OncoSec Medical Inc., which is developing its advanced-stage OncoSec Medical System (OMS) ElectroOncology therapies to treat solid tumors, today announced positive interim analysis of data from 81 subjects in a Phase IV study of primary and locally recurrent squamous cell carcinoma of the head and neck (HNSCC) treated with OMS ElectroChemotherapy in Europe.
Scientists investigating the cancer-fighting properties of artesunate - a drug commonly used to treat malaria - have found early evidence that combining it with an existing cancer drug has the potential to make each drug more effective than when used alone. They also found that regular treatment breaks could improve success levels.
DePuy Synthes Spine announced it is expanding its collaboration with Brainlab through the worldwide launch of navigation-ready instrumentation for its leading spine systems, and an exclusive global agreement to co-market Airo Mobile Intraoperative CT by Brainlab.
› Verified 7 days ago
| Provider Name | Brett Lorenz |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1932769528 PECOS PAC ID: 8921433749 Enrollment ID: I20200123002835 |
News Archive
A recent Reuters article reported that America's pharmaceutical research and biotechnology companies don't expect an industry increase as a result of broader insurance coverage proposed in health care reform.
Can scientists rid malaria from the Third World by simply feeding algae genetically engineered with a vaccine? That's the question biologists at UC San Diego sought to answer after they demonstrated last May that algae can be engineered to produce a vaccine that blocks malaria transmission.
OncoSec Medical Inc., which is developing its advanced-stage OncoSec Medical System (OMS) ElectroOncology therapies to treat solid tumors, today announced positive interim analysis of data from 81 subjects in a Phase IV study of primary and locally recurrent squamous cell carcinoma of the head and neck (HNSCC) treated with OMS ElectroChemotherapy in Europe.
Scientists investigating the cancer-fighting properties of artesunate - a drug commonly used to treat malaria - have found early evidence that combining it with an existing cancer drug has the potential to make each drug more effective than when used alone. They also found that regular treatment breaks could improve success levels.
DePuy Synthes Spine announced it is expanding its collaboration with Brainlab through the worldwide launch of navigation-ready instrumentation for its leading spine systems, and an exclusive global agreement to co-market Airo Mobile Intraoperative CT by Brainlab.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dakota Vision Center East 5012 S Bur Oak Pl, Sioux Falls, SD 57108-2228 Ph: (605) 361-1680 | Dakota Vision Center East 5012 S Bur Oak Pl, Sioux Falls, SD 57108-2228 Ph: (605) 361-1680 |
News Archive
A recent Reuters article reported that America's pharmaceutical research and biotechnology companies don't expect an industry increase as a result of broader insurance coverage proposed in health care reform.
Can scientists rid malaria from the Third World by simply feeding algae genetically engineered with a vaccine? That's the question biologists at UC San Diego sought to answer after they demonstrated last May that algae can be engineered to produce a vaccine that blocks malaria transmission.
OncoSec Medical Inc., which is developing its advanced-stage OncoSec Medical System (OMS) ElectroOncology therapies to treat solid tumors, today announced positive interim analysis of data from 81 subjects in a Phase IV study of primary and locally recurrent squamous cell carcinoma of the head and neck (HNSCC) treated with OMS ElectroChemotherapy in Europe.
Scientists investigating the cancer-fighting properties of artesunate - a drug commonly used to treat malaria - have found early evidence that combining it with an existing cancer drug has the potential to make each drug more effective than when used alone. They also found that regular treatment breaks could improve success levels.
DePuy Synthes Spine announced it is expanding its collaboration with Brainlab through the worldwide launch of navigation-ready instrumentation for its leading spine systems, and an exclusive global agreement to co-market Airo Mobile Intraoperative CT by Brainlab.
› Verified 7 days ago
Sivesind, Tims & Clarke, Prof. L.l.c. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 2210 W 69th St Ste 160, Sioux Falls, SD 57108 Phone: 605-331-2020 Fax: 605-638-9649 | |
Dr. Jarrell Freitag, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 2510 S Louise Ave, Sioux Falls, SD 57106 Phone: 605-361-1882 | |
Justin A Schweitzer, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 3101 W 57th St, Sioux Falls, SD 57108 Phone: 605-361-3937 Fax: 605-371-7199 | |
Dr. Kayla Karpuk, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 3101 W 57th St, Sioux Falls, SD 57108 Phone: 605-361-3937 | |
Thomas Billars, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 200 W 37th St, Sioux Falls, SD 57105 Phone: 605-336-2020 Fax: 605-725-2614 | |
Dr. Jordan Langel, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 2812 W 41st St, Sioux Falls, SD 57105 Phone: 605-338-3225 | |
Amrit Pal Singh, OD Optometrist Medicare: Medicare Enrolled Practice Location: 3101 W 57th St, Sioux Falls, SD 57108 Phone: 605-361-3937 Fax: 605-371-7199 |